$0.237
-0.004 (-1.62%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de KAPA por análisis de gráficos similares
Alphio's KAPA stock price prediction model matches the current Kairos Pharma Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.23 (-1.12%). The 1-week path is $0.23 (-1.57%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Kairos Pharma Ltd?
Kairos Pharma Ltd (KAPA) is not a good buy right now. The stock has seen a staggering year-to-date decline of 67.49% and a one-year change of 83.18%. Additionally, the current RSI of 26.144 indicates that the stock is oversold, but this does not guarantee a rebound. The forward P/E ratio is 0, reflecting a lack of profitability expectations, and the company has reported consistent net losses, with a net income of -1,654,000 USD in Q1 2026. The primary risk is the significant drop in stock price, which has decreased by 18.24% over the last five days, indicating ongoing bearish sentiment.
KAPA cerró en $0.24 el Friday, tras bajar -1.62%
Kairos Pharma Ltd (KAPA) last closed at $0.2371, losing -1.62%. These facts feed the 1-day and 1-week KAPA price prediction above.
Factores de la previsión
Los factores de la previsión de Kairos Pharma Ltd (KAPA) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de KAPA, ordenadas por similitud.
Análisis de estacionalidad de KAPA
Historically the probability of a positive August return for KAPA is 0.00%. January offers the highest probability of a positive month at 55.00%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de KAPA
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $1.10 | $1.15 | $1.27 | +384.22% |
| Sep 2026 | $1.00 | $1.12 | $1.30 | +373.01% |
| Oct 2026 | $0.95 | $1.09 | $1.26 | +359.54% |
| Nov 2026 | $0.84 | $0.96 | $1.13 | +306.54% |
| Dec 2026 | $0.96 | $0.96 | $0.98 | +306.54% |
En 2026, se proyecta que Kairos Pharma Ltd (KAPA) oscile entre $0.84 y $1.30.
Previsión mensual de Kairos Pharma Ltd para 2026
En Aug de 2026, se proyecta que Kairos Pharma Ltd promedie $1.15, con un mínimo de $1.10 y un máximo de $1.27.
En Sep de 2026, se proyecta que Kairos Pharma Ltd promedie $1.12, con un mínimo de $1.00 y un máximo de $1.30.
En Oct de 2026, se proyecta que Kairos Pharma Ltd promedie $1.09, con un mínimo de $0.95 y un máximo de $1.26.
En Nov de 2026, se proyecta que Kairos Pharma Ltd promedie $0.96, con un mínimo de $0.84 y un máximo de $1.13.
En Dec de 2026, se proyecta que Kairos Pharma Ltd promedie $0.96, con un mínimo de $0.96 y un máximo de $0.98.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.